Targeting CD47 as a Novel Immunotherapy for Breast Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.924740
Abstract: Nowadays, breast cancer has become the most common cancer worldwide with a high mortality rate. Immune checkpoint blockade holds great promise in tumor‐targeted therapy, and CD47 blockade as one immune therapy is undergoing various preclinical… read more here.
Keywords: cd47 novel; targeting cd47; breast cancer; novel immunotherapy ... See more keywords